SCHEMBL5772669

SCHEMBL5772669

O=C(N(CCCc1cnoc1-c1ccc(C(F)(F)F)cc1)CCCn1ccnc1)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.42
HDAC4 P56524 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HMOX1 P09601 1/20 0.39
GSK3A P49840 2/20 0.39
GSK3B P49841 2/20 0.39
QPCT Q16769 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ATP4A P20648 1/20 0.37
ATP4B P51164 1/20 0.37
TBXAS1 P24557 2/20 0.36
SCN9A Q15858 1/20 0.36
NPC1 O15118 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TP53 P04637 1/20 0.36
MDM2 Q00987 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773637 0.92 CYP19A1 (0.44) HDAC4HDAC6QPCTTBXAS1
SCHEMBL5775722 0.83 GSK3B (0.41) HDAC4GSK3BSMN1; SMN2
SCHEMBL5772985 0.81 GSK3B (0.41) GSK3BSMN1; SMN2
SCHEMBL5776662 0.81 TRPV1 (0.37) HDAC4HDAC6CYP1A2CYP3A4CYP2C9
SCHEMBL5773874 0.80 MAPT (0.42) CYP3A4CYP2C19TBXAS1SMN1; SMN2
SCHEMBL5774056 0.79 TRPV1 (0.38)
Trifluoroacetic Acid SCHEMBL5772663 0.79 IDE (0.49) HDAC4HDAC6GSK3AGSK3BCYP1A2
SCHEMBL5907124 0.79 FAAH (0.36)
SCHEMBL5774478 0.78 HIF1A (0.42) CYP3A4CYP2C19TBXAS1SMN1; SMN2
SCHEMBL5771105 0.78 GSK3B (0.39) GSK3BCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR NOS1 823/4885HDAC4 434/4885HDAC6 1324/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 NOS1 1198/4885HDAC4 497/4885HDAC6 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.